Consensus for the use of the alcohol biomarker phosphatidylethanol (PEth) for the assessment of abstinence and alcohol consumption in clinical and forensic practice (2022 Consensus of Basel)

WHO.International guide for monitoring alcohol consumption and related harm. World Health Organization Dep. of Mental Health and substance dependence.2000:51‐54.

[5]

10.1111/acer.13062

[6]

10.1016/j.yrtph.2018.01.029

[7]

10.1373/clinchem.2017.277525

Cited By

102

Remote alcohol biomarker monitoring to promote drinking reductions among people with HIV: A proof-of-concept pilot study

Alan Z Sheinfil, Daniela Morales-Aseff · 2026

Journal of Substance Use and Addict...

Metrics

102

Citations

7

References

Details

Published: Jul 18, 2022
Vol/Issue: 14(10)
Pages: 1800-1802
License: View

Authors

M

Marc Luginbühl

PEth‐NET Muttenz Switzerland

F

Friedrich M. Wurst

Psychiatric University Hospital Basel University of Basel Basel Switzerland

F

Frederike Stöth

Institute of Forensic Medicine Bern University of Bern Bern Switzerland

W

Wolfgang Weinmann

Institute of Forensic Medicine Bern University of Bern Bern Switzerland

C

Christophe P. Stove

Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences Ghent University Ghent Belgium

K

Katleen Van Uytfanghe

Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences Ghent University Ghent Belgium

Funding

Swiss Foundation for Alcohol Research

Cite This Article

Marc Luginbühl, Friedrich M. Wurst, Frederike Stöth, et al. (2022). Consensus for the use of the alcohol biomarker phosphatidylethanol (PEth) for the assessment of abstinence and alcohol consumption in clinical and forensic practice (2022 Consensus of Basel). Drug Testing and Analysis, 14(10), 1800-1802. https://doi.org/10.1002/dta.3340

Consensus for the use of the alcohol biomarker phosphatidylethanol (PEth) for the assessment of abstinence and alcohol consumption in clinical and forensic practice (2022 Consensus of Basel)

You May Also Like